1. Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. Issue 3 (28th June 2021) Authors: Drexel, Heinz; Pocock, Stuart J; Lewis, Basil S; Saely, Christoph H; Kaski, Juan Carlos; Rosano, Giuseppe M C; Tautermann, Gerda; Huber, Kurt; Dopheide, Joern F; Mader, Arthur; Niessner, Alexander; Savarese, Gianluigi; Schmidt, Thomas A; Semb, Anne Grete; Tamargo, Juan; Wassmann, Sven; Clodi, Mar... Journal: European heart journal Issue: Volume 8:Issue 3(2022) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials. Issue 5 (2nd November 2020) Authors: Drexel, Heinz; Lewis, Basil S; Rosano, Giuseppe M C; Saely, Christoph H; Tautermann, Gerda; Huber, Kurt; Dopheide, Joern F; Kaski, Juan Carlos; Mader, Arthur; Niessner, Alexander; Savarese, Gianluigi; Schmidt, Thomas A; Semb, AnneGrete; Tamargo, Juan; Wassmann, Sven; Per Kjeldsen, Keld; Agewall, ... Journal: European heart journal Issue: Volume 7:Issue 5(2021) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗